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Aims To evaluate whether comprehensive evaluation of coronary anatomy and delayed enhancement (DE) by multidetec-
tor-computed tomography (MDCT) would allow determination of etiology of left ventricular dysfunction (LVD) as
compared with coronary angiography (CA) and DE-magnetic resonance (CMR).
Methods
and results
Seventy-one consecutive patients (50 males, 59+16 years) with LVD (ejection fraction: 26+11%) of unknown
etiology underwent MDCT, LGE (late Gd-DTPA-enhanced)-CMR and CA. Patients were classiﬁed into four
groups according to coronary artery disease (CAD) by CA and LGE-CMR patterns. Patients (n ¼ 24) with CAD
and transmural or sub-endocardial DE by CMR were considered having deﬁnite ischaemic LVD (group 1). Patients
(n ¼ 36) without CAD by CA and with no/atypical LGE-CMR were considered non-ischaemic LVD (group 2).
Further we identiﬁed four patients with transmural DE but no CAD (group 3) and seven patients with CAD but
no DE (group 4). On per-patient basis, combined coronary and DE-MDCT had excellent agreement (k ¼ 0.89;
P , 0.001) with CA/LGE-CMR to classify patients into the same four groups. Sensitivity, speciﬁcity and accuracy
of MDCT were 97, 92 and 94%, respectively for detecting patients with deﬁnite (group 1) or likely (groups 3 and
4) ischaemic LVD.
Conclusion Combined coronary and DE-MDCT can accurately differentiate ischaemic vs. non-ischaemic etiology of LVD.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Recognizing the underlying etiology of left ventricular dysfunction
(LVD) is essential for deﬁning prognosis and selecting treatment
of patients. Indeed coronary artery disease (CAD) is the most
common cause of LVD,
1 but may have worse outcome than
some subtypes of non-ischaemic dilated cardiomyopathy
(DCM).
2 Conversely, coronary revascularization can improve
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especially if myocardial viability is present.
3
Since non-invasive tests for detection of CAD perform poorly in
patients with LVD, current guidelines
4 recommend performing
invasive coronary angiography (CA) to determine the underlying
cause of LVD. Yet, this invasive approach is costly and carries a
non-negligible risk of complications. More recently, late gadolinium
diethylenetriamine penta-acetic acid (Gd-DTPA)-enhanced (LGE)
5
cardiovascular magnetic resonance (CMR) has also been proposed
to assess the etiology of LVD. Different patterns of LGE have been
described in patients with LVD.
6,7 Ischaemic LVD is typically associ-
ated with sub-endocardial or transmural LGE patterns. In contrast,
patients with non-ischaemic DCM, usually display either no LGE,
or in mid-ventricular or sub-epicardial LGE patterns,
7 quite
different from those seen in CAD patients.
Recently, it was demonstrated that also multidetector-
computed tomography (MDCT) can detect myocardial necrosis
and ﬁbrosis on LGE images both in animals
8–10 and humans.
9,11–
13 MDCT thus offers the unique possibility of combining myocar-
dial tissue characterization with non-invasive coronary imaging in a
single exam that lasts ,15 min.
Accordingly, the aim of the present study was to evaluate the
feasibility and diagnostic accuracy of using combined coronary
and delayed enhancement (DE)-MDCT for determining the etiol-
ogy of LVD. For this purpose, we compared coronary and
DE-MDCT in 71 patients with LVD of unknown etiology to inva-
sive CA and LGE-CMR.
Methods
Patient population
Consecutive patients with reduced left ventricular (LV) ejection frac-
tion (,50%) referred to our institution for evaluation of etiology of
LVD by CA and LGE-CMR were prospectively screened for inclusion
into the study. Patients with an established diagnosis of LVD (deﬁnite
history of infarction or prior CA) were not considered for inclusion.
Presence of Q-waves on ECG was not considered a deﬁnite proof
for ischaemic LVD and thus not an exclusion criterion. Other exclu-
sion criteria were haemodynamic instability, atrial ﬁbrillation, renal
failure (serum creatinine .1.4 mg/dL), known allergy to iodinated
contrast agents, or any contraindication to CMR imaging (cerebral
aneurysm clips, pacemaker, or severe claustrophobia). The study
protocol complied with the Declaration of Helsinki and was approved
by the local Ethic Committee. All patients gave informed consent prior
to inclusion into the study.
Study protocol
Patients underwent DE and coronary MDCT as well as clinically indi-
cated CA and LGE-CMR in random order within 1 month. Because
many patients had clinically symptomatic congestive heart failure, no
systematic beta-blockers were given prior to MDCT. Also no sublin-
gual nitroglycerin was given. Patients were not excluded based on
high rate.
Multidetector row coronary computed
tomography
MDCT was performed using a 40-slice (n ¼ 35 patients) or a 64-slice
(n ¼ 36 patients) system (Brilliance 40 and 64, respectively, Philips
Medical Systems, Cleveland, OH, USA) as previously described.
14
The two systems had identical spatial and temporal resolution as
well as rotation speed. They differed only in detector coverage
length, which allowed 40% shorter scanning time for the 64-slice
with respect to the 40-slice system. Coronary images were acquired
immediately after intravenous injection of 120 mL of non-ionic con-
trast (Iomeron 400, Bracco, Milan, Italy) at a rate of 4 mL/min. Scan
parameters were: tube voltage 120 kV and effective tube current
600 mA (for 40-slice MDCT) and 720 mA (for 64-slice MDCT). A
second series of gated breath-hold images was acquired for DE
imaging 10 min after contrast injection at the same location, but with
lower tube current (400/600 mA) and voltage (80 kV) to increase
signal-to-noise and reduce dose. Dose modulation was used only for
patients with HR ,70 b.p.m. Data sets were reconstructed at 75% of
cardiac cycle with additional reconstructions at other phases if
needed. Late images were reconstructed with a soft kernel (type CA),
and resliced into serial 10 mm thick short-axis and two-, three- and
four-chamber long-axis slices.
9 Total estimated radiation dose for both
scans calculated from dose length product was 17.8+3.3 mSv (70%
resulting from the coronary scan and 30% from the DE imaging).
LGE-cardiovascular magnetic resonance
LGE-CMR was performed on a 1.5 Tesla system (Philips Intera CV,
Best, The Netherlands). Cine-breath-hold steady state free precession
functional images were acquired in short-axis and two-, three- and
four-chamber views. Two-dimensional (2D) and 3D short-axis and
two-, three- and four-chamber LGE images were acquired 10–
15 min after injection of 0.20 mmol/kg Gadodiamide (Omniscan,
Nycomed) as previously described.
9 Inversion recovery time was indi-
vidually adapted (250–300 ms) based on a lock–locker sequence to
null the signal of normal myocardium and maximize contrast
between regions of LGE and normal myocardium.
LGE-CMR images were interpreted visually by one reader (A.C.P.)
blinded to all clinical, CA and MDCT data. In each patient, presence
and type of LGE pattern (typical ischaemic, i.e. sub-endocardial or
transmural vs. typical non-ischaemic, i.e. mid-ventricular, patchy, or
sub-epicardial) were recorded in a 17-segment AHA model.
Coronary angiography
Selective CA in multiple orthogonal projections was evaluated by
different clinical physicians unaware of the MDCT results. The stan-
dard 16-segment American Heart Association classiﬁcation system
was used.
15 All visually identiﬁed stenoses were measured quantitat-
ively in two orthogonal views by a quantitative CA (QCA) with the
CAAS II software (QCA, Cardiovascular Angiographic Analysis
System II, Pie Medical Equipment, Switzerland), using catheter-based
image calibration and automated vessel contour detection. Signiﬁcant
CAD was considered if diameter stenosis exceeded 50% in coronary
segments .1.5 mm.
Data analysis
Coronary and LGE-MDCT images were transferred onto a dedicated
workstation (Mxview, Philips Medical Systems). All patient-relevant
information was removed and anonymous images were analysed
ofﬂine by the visual consensual reading of two cardiologists (B.G.
and J.B.L.P.D.W.) who were blinded to the patient’s clinical infor-
mation, CA and LGE-CMR. Coronary images were interpreted on
the data set containing the fewest motion artefacts. Using axial data
sets, multiplanar reformations in various directions and maximum
intensity projections, both readers ﬁrst determined which segments
were assessable and then visually categorized the severity of diameter
Etiology of LV dysfunction by CT 2545stenosis as being ,50% or  50%. Presence and type of MDCT-DE
pattern were visually interpreted by the two reviewers on short-axis
and two-, three- and four-chamber long-axis images in the same
17-segment model as CMR.
Patient classiﬁcation
According to the results of CA and LGE-CMR, four groups of patients
were identiﬁed. Group 1 consisted of patients who satisﬁed the criteria
of Felker et al.
16 for ischaemic LVD by CA, i.e. signiﬁcant CAD stenosis
in at least two coronary arteries, or in the proximal left anterior
descending coronary artery (LAD) or left main coronary artery
(LM); and who had also sub-endocardial or transmural LGE. Group
two consisted of patients who had no signiﬁcant (,50% stenosis)
CAD, or CAD in only one small vessel, and who had either no LGE
or a LGE pattern-described non-ischaemic LVD (mid-ventricular or
sub-epicardial LGE).
6,7 Group 3 consisted of patients without signiﬁ-
cant CAD, but with sub-endocardial or transmural LGE typical of
ischaemic LVD. Finally, patients with CAD but without LGE or with
non-ischaemic LGE patterns were classiﬁed in group 4. The same
classiﬁcation and criteria were used to classify patients using coronary
and DE-MDCT.
Statistical analysis
Continuous values are reported as mean+1 standard deviation. Stat-
istical analysis was made using SPSS 11.5 software. We estimated that
prevalence of CAD in patients with LVD would be 50% and that
MDCT would have 90% sensitivity and speciﬁcity to detect CAD on
per-patient basis. Based on these assumptions we estimated that we
need 35 with and 35 without disease to deﬁne sensitivity and speci-
ﬁcity of MDCT with a 95% conﬁdence interval (CI) of +10%. Baseline
characteristics of patients in the four groups were compared using
ANOVA (continuous variables) and Kruskal–Wallis test (categorical
variables). The diagnostic accuracy of coronary and DE-MDCT on seg-
mental basis was evaluated using CA and LGE-CMR as reference stan-
dards. Diagnostic accuracy for detection of CAD and DE patterns was
expressed as per cent with 95% CI. Agreement between the four
groups of patients was assessed using k-statistic. We computed predic-
tive value of MDCT for the diagnosis of certain (group 1) and likely
(groups 3 and 4) ischaemic aetiology of LVD. All tests were two-sided
and P , 0.05 was considered indicative of statistical signiﬁcance.
Results
Study population
Figure 1 shows included and excluded patients. The 71 patients
enrolled in this study successfully completed CA, MDCT, and
CMR without complications. Examples of coronary and
DE-MDCT, CA, and LGE-CMR images obtained in ﬁve representa-
tive patients are shown in Figure 2. Patient characteristics are sum-
marized in Table 1. Most patients had new onset heart failure (,3
months duration of symptoms).
Coronary angiography and cardiovascular
magnetic resonance
According to CA, 31 patients presented signiﬁcant CAD, i.e. two
patients had single-vessel disease (both had proximal LAD), nine
had two-vessel disease and 20 presented with three-vessel
disease. According to CMR, 24 patients had transmural LGE,
four had sub-endocardial LGE, 11 had mid-ventricular or epicardial
LGE and one patient had sub-epicardial and mid-ventricular LGE
which extended transmurally in some regions.
Classiﬁcation of patients by combining
coronary angiography and late
Gd-DTPA-enhanced cardiovascular
magnetic resonance
Classiﬁcation of patients by CA and LGE-CMR is shown in Figure 3.
Among the 31 patients with CAD, 24 had transmural (n ¼ 20) or
sub-endocardial (n ¼ 4) LGE (group 1). Among the 40 patients
without signiﬁcant CAD, 24 had no LGE on CMR, while 11
(15%) displayed mid-ventricular or sub-epicardial LGE and one
patient presented with both a transmural and mid- and sub-
epicardial LGE (the last patient was classiﬁed as a group 2
patient). Four patients without signiﬁcant CAD, had transmural
LGE on CMR (group 3). Finally seven patients with CAD (one
with single proximal LAD stenosis, one with two-vessel disease
involving the proximal LAD and distal left circumﬂex coronary
artery (LCX), four patients with three-vessel disease and one
patient with a single dominant right coronary artery (RCA) and
no LM) had no LGE on CMR (group 4).
Multidetector-computed tomography
Average heart rate during MDCT was 77+14 (53–118 b.p.m.).
No patient was excluded because of poor image quality. According
to coronary MDCT, 33 patients exhibited signiﬁcant CAD.
Detection of CAD by MDCT on per-patient basis had very high
agreement with CA (k ¼ 0.94; P , 0.001). MDCT was 100%
(31/31) sensitive, 95% (95% CI: 88–100%) (38/40) speciﬁc, and
97% (95% CI: 89–100%) (69/71) accurate, for identifying CAD
on per-patient basis. There were no false negative detections
and only two false positive identiﬁcations of CAD by MDCT,
Figure 1 Flow chart illustrating included and excluded patients.
J.-B. le Polain de Waroux et al. 2546both related to severe coronary calciﬁcations that led to over-
estimation of non-signiﬁcant stenoses.
On late images, MDCT identiﬁed 27 patients with transmural
DE, three patients with sub-endocardial DE, 10 patients with
mid-ventricular or epicardial DE and one patient who had
mid-ventricular, sub-epicardial, and transmural DE. One patient
with mid-ventricular LGE (non-ischaemic pattern) and one patient
with transmural LGE by CMR were not identiﬁed by DE-MDCT.
These false negatives were due to poor image quality and low
signal-to-noise ratio. There were three false positive identiﬁcations
of DE-MDCT (all of them considered ischaemic pattern). They
were related to artefacts related to either adjacent bone structures
(n ¼ 2) or motion (n ¼ 1). Overall DE-MDCT had very good
agreement (k ¼ 0.88; P , 0.001) for detection of sub-endocardial
or transmural DE using LGE-CMR as reference. The sensitivity
for detection of sub-endocardial or transmural necrosis was 96%
(28/29) (95% CI: 90–100%). Speciﬁcity was 92% (39/42) (95% CI:
85–100%).Diagnosticaccuracywas94%(67/71)(95%CI:89–100%).
Patient classiﬁcation by combining
coronary angiography and delayed
enhancement multidetector-computed
tomography
By combining information on coronary anatomy and of DE by
MDCT, we classiﬁed patients into the same four groups as by
CA and CMR. This classiﬁcation of patients by the combination
of coronary and DE-MDCT had very good agreement with the
Figure 2 Examples of coronary (panel I) and delayed enhancement (DE)-multidetector-computed tomography (MDCT) (panels III and V) in
ﬁve representative patients and their correlations to coronary angiography (panel II) and LGE-CMR (late Gd-DTPA-enhanced cardiovascular
magnetic resonance; panels IV and VI). (A) No coronary artery disease (CAD) and absence of DE. (B) No CAD and mid-ventricular DE. (C)
Occlusion of the proximal LAD (yellow arrow) with transmural DE in the apex, septum and antero-septal region (red arrows) and mural
thrombus (green arrows). (D) Absence of CAD with transmural inferior necrosis. (E) Proximal and mid-LAD and ﬁrst diagonal stenosis
(yellow arrows) without DE.
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(k ¼ 0.89; P , 0.001, Table 2). Only ﬁve patients were misclassiﬁed
with respect to their suspected etiology of LVD. Among the two
false positive detections of CAD, one was a true negative detection
of DE-MDCT. The patient was thus misclassiﬁed as group 4 instead
of group 2). The second false positive detection of CAD was also
erroneously considered to have ischaemic pattern with DE-MDCT
and thus misclassiﬁed as group 1 instead of group 2). There was a
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Table 1 Patient characteristics
Group 1 (n 5 24) Group 2 (n 5 36) Group 3 (n 5 4) Group 4 (n 5 7)
Demographics
Male/Female 22/2 21/15 3/1 4/3
Age (years) 62+10 56+19 58+22 63+16
Framingham risk (%) 13+71 3 +33 7+81 5 +9
NYHA class
I 3 (12%) 3 (8%) 0 (0%) 1 (14%)
II 7 (29%) 11 (30%) 2 (50%) 1 (14%)
III 13 (54%) 20 (55%) 1 (25%) 3 (43%)
IV 1 (4%) 2 (6%) 1 (25%) 2 (29%)
ECG
Q-waves 10 (41%) 4 (11%) 0 (0%) 0 0(%)
LBBB 3 (12%) 13 (36%) 2 (50%) 1 (14%)
CMR
EF (%) 25+11 26+12 29+13 28+7
EDV (mL) 280+91 248+111 233+124 214+45
CAD by CA
0 vx 0 (0%) 35 (97%) 4 (100%) 0 (0%)
1 vx 1 (4%) 1 (3%) 0 (0%) 1 (14%)
2 vx 6 (25%) 0 (0%) 0 (0%) 2 (29%)
3 vx 17 (71%) 0 (0%) 0 (0%) 4 (57%)
CA, coronary angiography; CAD, coronary artery disease; EF, ejection fraction; EDV, end-diastolic volume; LBBB, left bundle branch block; NYHA, New York Heart Association
class.
Figure 3 Classiﬁcation of patients according to coronary angiography and cardiovascular magnetic resonance.
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without CAD (misclassiﬁcation of group 3 vs. group 2) and in a
patient correctly identiﬁed to have CAD (misclassiﬁcation as
group 4 instead of group 1). In a ﬁfth patient correctly identiﬁed
not to have CAD, ischaemic type DE-MDCT was missed. Thus
this patient was misclassiﬁed as group 2 instead of group 3. Finally
a non-ischaemic (mid-ventricular DE pattern) was missed. Since
this occurred in a patient who was correctly identiﬁed not to
have CAD, the patient’s group did not change (remained group 2).
The combination of coronary and DE-MDCT was 97% (95% CI:
83–100%) (34/37) sensitive, 92% (33/36) (95% CI: 82–100%)
speciﬁc, and 94% (95% CI: 89–100%) (67/71) accurate, for detecting
deﬁnite (group 1) or probable (groups 3 and 4) ischaemic LVD as
compared with CA and LGE-CMR. Since ‘group 3’ patients had
typical ischaemic LGE, but ‘no’ CAD by CA, these probably rep-
resent embolic infarcts and/or transient occlusion followed by spon-
taneous recanalization. Thus, from a more clinical perspective, a
second classiﬁcation relative to the aetiology of the LVD was per-
formed by including those patients as group 1. Using this second
classiﬁcation and considering only group 1 patients as deﬁnite ischae-
mic LVD, DE-MDCT was 96% (95% CI: 83–100%) (27/28) sensitive,
90% (40/43) (95% CI: 85–100%) speciﬁc, and 94% (95% CI: 89–
100%) (67/71) accurate as compared with CA and LGE-CMR.
Discussion
Delineation of the etiology of left
ventricular dysfunction
Precise delineation of the etiology of LVD is important for the risk
stratiﬁcation and treatment selection in patients with LVD. Unfor-
tunately, clear deﬁnition of the etiology of LVD is not always
straightforward. CA is currently considered the reference standard
for detecting whether a patient has ischaemic LVD or non-
ischaemic DCM. However, detection of epicardial stenosis by
CA alone has its own limitations and different criteria for deﬁnition
of ischaemic LVD have been proposed.
16 Indeed, the detection of
epicardial coronary artery stenosis by CA in a patient with LVD
does not necessarily indicate that CAD is the underlying cause
of LVD, as the fortuitous association of non-ischaemic DCM
with CAD can be seen in older patients with coronary risk
factors. On the other hand, a normal CA does not necessarily
exclude CAD as initial cause of LVD, since patients with myocar-
dial infarction may experience spontaneous recanalization of the
culprit coronary artery.
Tissue imaging by LGE-CMR offers alternative and complemen-
tary information to elucidate the underlying mechanism of LVD.
Indeed, it allows detecting myocardial ﬁbrosis and necrosis
with high spatial resolution and good histological correlation.
5
Recent studies have shown that LGE-CMR allows differentiating
ischaemic from non-ischaemic LVD by identifying different contrast
enhancement patterns.
6,7,17–19 Indeed, the majority of patients
with ischaemic LVD exhibit at least one small region of either
sub-endocardial or transmural LGE,
6,7 although some may only
be microscopically visible and occur at very late states of dysfunc-
tion.
20 In contrast, patients with non-ischaemic LVD usually display
no LGE or LGE regions whose spatial distribution differs from that
seen in CAD, i.e. mid-ventricular or sub-epicardial DE zones.
7 It
was suggested that these ‘atypical’ LGE patterns may result from
chronic or healed myocarditis.
21
It is interesting to note that in the present study, classiﬁcation of
etiology by CA and CMR differed in a signiﬁcant number of
patients. Indeed, besides patients with both CAD and typical sub-
endocardial or transmural LGE (group 1), and without both CAD
and LGE (group 2), we came across several patients who deﬁnitely
had CAD but did not show LGE or displayed ischaemic LGE
pattern but had no signiﬁcant CAD. We considered that the ﬁrst
group of patients without signiﬁcant CAD, but with LGE (group
3) had likely undergone an embolic infarct or had reperfused
their coronary artery after a transitory occlusion.
6 Many of these
patients had indeed CAD, but without signiﬁcant (.50%)
reduction of the lumen of the coronary arteries.
The classiﬁcation of the last group of patients with CAD, but
without typical LGE (group 4) is somewhat more problematic.
These patients might have a pure form of collateral dependent
non-infarcted ‘hibernating myocardium’.
22,23 They could also have
non-ischaemic DCM with secondary presence of CAD. Since we
did not perform endocardial biopsies in our patients, the precise
etiology of LVD in these patients remained uncertain. These intri-
cacies illustrate clearly, that a correct classiﬁcation of the etiology
of LVD is difﬁcult and requires not only depiction of coronary
anatomy, but also identiﬁcation of myocardial tissue damage by
LGE-CMR or MDCT.
Use of multidetector-computed
tomography to deﬁne the etiology of left
ventricular dysfunction
So far, only few prior studies have employed MDCT to character-
ize patients with LVD. Budoff et al.
24,25 reported that the calcium
score alone had 97–99% sensitivity and 68–82% speciﬁcity for
identiﬁcation of ischaemic vs. non-ischaemic LVD and that it also
was more accurate than thallium stress testing for delineating the
etiology of LVD. More recently, Andreini et al.
26 and Cornily
et al.
27 evaluated the feasibility of using 16-slice MDCT for detect-
ing coronary stenosis in LVD patients and reported good diagnos-
tic accuracy of detecting CAD on segmental basis. Although
................................................................
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Table 2 Comparison of patient classiﬁcation by
multidetector-computed tomography vs. coronary
angiography and cardiovascular magnetic resonance
Coronary angiography and LGE-CMR
Group 1 Group 2 Group 3 Group 4 Total
MDCT
Group 1 24 1 0 1 26
Group 2 0 33 1 0 34
Group 3 0 1 3 0 4
Group 4 0 1 0 6 7
Total 24 36 4 7 71
k ¼ 0.89; P , 0.001.
Etiology of LV dysfunction by CT 2549detection of DE by MDCT was reported in infarction,
9,11–13 myo-
carditis,
21–23 sarcoidosis,
28 and hypertrophic cardiomyopathy,
29
DE-MDCT has not yet been proposed for detection of etiology
of LVD.
The present study is thus the ﬁrst to evaluate the combination of
coronary and DE-MDCT to assess the etiology of LVD in a large
number of patients with LVD of unknown origin. Our results indi-
cate that MDCT has a high accuracy for detection of signiﬁcant
CAD in comparison with CA in this population and that it is
capable of detecting similar DE patterns as LGE-CMR, with an
equally good accuracy. Accordingly, in our study, MDCT allowed
to accurately deﬁne the origin of LVD in comparison with CA
and CMR. The major advantage of using MDCT in this setting is
that it allows for a comprehensive assessment in a single non-
invasive test. An additional advantage of MDCT is its more wide-
spread availability, compared with CA and CMR and that it can
be performed in patients with implantable devices, such as resyn-
chronization pacemakers or AICD. One should nonetheless recog-
nize that the use of MDCT in patients with LVD also carries
signiﬁcant limitations. Since injection of iodinated contrast can
aggravate pre-existing renal failure, it is contraindicated in patients
with renal failure. This condition is however common in patients
with LVD due to low cardiac output, coexisting renal disease
and treatment with diuretics or inhibitors of the renin–angioten-
sin–aldosterone system. Injection of large volumes of iodinated
contrast agents at high injection rates might also cause haemo-
dynamic complications, such as acute pulmonary oedema. Patients
should therefore be well monitored. No such complication was
however observed in our study. Another limitation of current ret-
rospectively gated DE-MDCT technology is the high radiation dose
with the potential of radiation-induced cancer.
30 As opposed to
using invasive angiography as a ﬁrst test, which may allow the possi-
bility of coronary revascularization in the same setting; using
MDCT as a screening test for CAD might potentially cause
double radiation exposure if invasive angiography will be needed
later for revascularization purposes. The late-enhanced study adds
30% additional dose (.5 mSv) to the dose of CA-MDCT. Such
considerations of radiation-induced cancer are certainly important
in young asymptomatic patients with long life expectancy, where
the beneﬁts of the test must be weighted against the theoretical
risk of inducing cancer due to radiation exposure. However in the
present population of older patients with severe LVD, the potential
harm from radiation is likely negligible as opposed to disease-related
prognosis.
31 Also in the future, dose exposure of MDCT will likely
be reduced signiﬁcantly by prospective ECG gating.
32
A ﬁnal important limitation is that image quality of DE-MDCT is
currently less than that of LGE-CMR. It may not allow detection of
very small areas of necrosis. Yet, in the present study, most patients
presented with large areas of DE that could easily be picked up by
MDCT, and agreement of DE-MDCT and LGE-CMR was high.
Other value of delayed enhancement
multidetector-computed tomography in
patients with left ventricular dysfunction
In patients with CAD, the presence of LGE by CMR indicates irre-
versible myocardial necrosis, and thus non-viable myocardium and
a low likelihood of functional recovery after revascularization.
33
Detection of LGE is thus useful for deciding whether patients
with ischaemic LVD should undergo revascularization or not.
The ability to predict myocardial viability was also recently demon-
strated for DE-MDCT.
13,34 LGE as detected by CMR also carries
prognostic information in patients with LVD. Kwong et al.
35
demonstrated that the presence of unrecognized LGE in CAD
patients unfavourably inﬂuenced outcome. Similarly in patients
with non-ischaemic DCM, Assomull et al.
36 reported that the pre-
sence of LGE was associated with higher risk of death. Given the
high degree of concordance between DE-MDCT and LGE-CMR
patterns, one might anticipate that DE-MDCT would carry also a
similar prognostic value as CMR in LVD patients. This was
however not veriﬁed in the present work.
Study limitations
The present work was performed using MDCT scanners with,
respectively, 40 and 64 detector rows and 420 ms rotation
speed. The diagnostic performance of more recent dual-source
MDCT scanners in patients with LVD and high heart rates might
be even higher.
37,38 Another limitation of this present study is
that we used CA and LGE-CMR as gold standard for classiﬁcation
of etiology of LVD. Histological veriﬁcation by endomyocardial
biopsy was not performed in our study.
Conclusion
The present study demonstrates that combined coronary and
DE-MDCT can identify the underlying etiology of patients with
LVD in a manner much similar to CMR and CA. Our results also
raised questions about the use of a single standard of reference
for the diagnosis of LVD etiology since signiﬁcant discrepancies
between LGE-CMR and CA were observed in several patients. In
this setting, combination of coronary and DE-MDCT may be
thus extremely useful for better understanding of the etiology of
LVD. DE-MDCT being more widely available, it could thus allow
for a faster and cheaper characterization of the etiology of LVD.
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